Community Health Systems, Inc.
CYHCommunity Health Systems, Inc. (CYH) is a healthcare company that owns, leases, and operates hospitals and outpatient facilities across the United States. Founded in the early 1980s, it focuses on providing acute care services and improving community health through a network of community hospitals. The company aims to deliver quality healthcare solutions in diverse markets.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 28, 2012 | $0.25 | 2012-12-13 | 2012-12-17 |
Dividends Summary
- Consistent Payer: Community Health Systems, Inc. has rewarded shareholders with 1 dividend payments over the past 0 years.
- Total Returned Value: Investors who held CYH shares during this period received a total of $0.25 per share in dividend income.
- Latest Payout: The most recent dividend of $0.25/share was paid 4774 days ago, on December 28, 2012.
Company News
Tenet Healthcare demonstrates strong financial performance with impressive Q2 2025 results, featuring revenue growth, margin expansion, and strategic focus on ambulatory care. The company shows potential for growth despite potential future Medicaid policy challenges.
Athens Orthopedic Clinic (AOC) has appointed Mike Boblitz as its new Chief Executive Officer, bringing over two decades of healthcare leadership experience. Boblitz aims to guide AOC through the evolving healthcare landscape, focusing on strategy, operational excellence, and patient-centered care.
Newsweek, in partnership with Statista, has released its rankings for America's Best Physical Rehabilitation Centers 2024. The assessment incorporated quality metrics and a national survey of healthcare professionals to identify the top facilities across the nation.
Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (CYH) due to the company's decision to not move forward with the sale of two North Carolina hospitals to Novant Health, Inc. following a court ruling.
Community Health (CYH) is now set to source drugs from the Cost Plus Drugs Marketplace under the new expanded partnership.
